What Makes Kindred Healthcare (KND) a Strong Sell?

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.

One such stock that you may want to consider dropping is Kindred Healthcare Inc. KND, which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #5 (Strong Sell) further confirms weakness in KND.

A key reason for this move has been the negative trend in earnings estimate revisions. For the full year, we have seen 4 estimates moving down in the past 30 days, compared with no upward revisions. This trend has caused the consensus estimate to trend lower, going from 90 cents a share a month ago to its current level of 74 cents.

Also, for the current quarter, Kindred Healthcare has seen 3 downward estimate revisions versus no revisions in the opposite direction, dragging the consensus estimate down to 8 cents a share from 20 cents over the past 30 days.  

The stock also has seen some pretty dismal trading lately, as the share price has dropped 34.9% in the past month.

KINDRED HLTHCR Price and Consensus

KINDRED HLTHCR Price and Consensus | KINDRED HLTHCR Quote

So it may not be a good decision to keep this stock in your portfolio anymore, at least if you don’t have a long time horizon to wait.

If you are still interested in the Medical-Nursing Homes industry, you may instead consider a better-ranked stock - Genesis Healthcare, Inc. GEN. The stock currently holds a Zacks Rank #2 (Buy) and may be a better selection at this time. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
KINDRED HLTHCR (KND): Free Stock Analysis Report
 
GENESIS HLTHCR (GEN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research